Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients.

Published in: PloS one (2020)

We did not find differences of reported COVID-19 cases between treated and untreated groups, indicating a lack of protection by regular administration of chloroquine and its derivative drugs on COVID-19 infection. Of relevance, data indicates that patients that regularly take chloroquine derivatives are exposed to SARS-CoV-2 infection and must take the same protection measures as the general population.

Keyphrases

end stage renal disease
newly diagnosed
sars cov
coronavirus disease
chronic kidney disease
ejection fraction
respiratory syndrome coronavirus
deep learning
plasmodium falciparum